Please use this identifier to cite or link to this item:
Appears in Collections:Faculty of Health Sciences and Sport Journal Articles
Peer Review Status: Refereed
Title: A scoping review of the pharmaceutical care needs of people with sensory loss
Author(s): Killick, Kirsty
Macaden, Leah
Smith, Annetta
Kroll, Thilo
Stoddart, Kathleen
Watson, Margaret C
Keywords: hearing loss
patient safety
pharmaceutical services
scoping review
vision disorders
Issue Date: 31-Oct-2018
Citation: Killick K, Macaden L, Smith A, Kroll T, Stoddart K & Watson MC (2018) A scoping review of the pharmaceutical care needs of people with sensory loss. International Journal of Pharmacy Practice, 26 (5), pp. 380-386.
Abstract: Objectives This scoping review collated evidence of the pharmaceutical care needs of people with sensory loss (SL). Methods Electronic databases were searched with no limit on year of publication: Medline (1946); Embase; Cinahl (1979); and Web of Science (1985). Search terms included the following: pharmacy; sight/hearing/dual impairment. Studies were included if they involved people with SL requiring pharmaceutical care and/or pharmacists/pharmacy support staff providing pharmaceutical care for people with SL. All study designs were eligible. This was a scoping review, and as such, the quality of studies was not formally evaluated. Key findings Eleven studies were included. People with SL had lower levels of medication knowledge than their peers without SL. People with SL were identified as being at higher risk of iatrogenic harm than people without SL. Communication was a barrier to the provision of pharmaceutical care for people with hearing loss, with pharmacists relying on the provision of written information. The prevalence of SL increases with age, yet only two studies included older people. No studies involved family or carers of people with SL, people with dual loss or people with SL receiving polypharmacy. Conclusions There is a paucity of data regarding the pharmaceutical care needs of people with SL. Unmet pharmaceutical care needs put people with SL at increased risk of harm from their medicines. A detailed understanding of the needs of people with SL is required which will inform future delivery of pharmaceutical care for this vulnerable population.
DOI Link: 10.1111/ijpp.12456
Rights: © 2018 The Authors. International Journal of Pharmacy Practice published by John Wiley & Sons Ltd on behalf of Royal Pharmaceutical Society This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Files in This Item:
File Description SizeFormat 
Killick_et_al-2018-International_Journal_of_Pharmacy_Practice.pdfFulltext - Published Version218.41 kBAdobe PDFView/Open

This item is protected by original copyright

Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

If you believe that any material held in STORRE infringes copyright, please contact providing details and we will remove the Work from public display in STORRE and investigate your claim.